How Long Can You Live Without Treating Cancer? (2026 Update)

Survival time without treatment isn't something the source material addresses—it varies so widely by cancer type, stage, and individual condition that it can't be generalized. However, national survival rate statistics for patients who did receive treatment are available, and we'll walk through those as a point of reference.

Key Takeaways

• There's no figure in the available data for survival time without treatment, so we're unable to answer that specific question.
• For patients who did receive treatment, the 5-year relative survival rates based on Korea's 2019–2023 national cancer registry statistics are 96.9% for prostate cancer, 78.6% for stomach cancer, 75.6% for colorectal cancer, 40.4% for liver cancer, and 55.7% for leukemia, with an all-cancers-combined rate of 73.7%.
• These figures are nationwide statistics for Korea as a whole, not the results of any particular hospital, and they are not numbers that predict an individual's outcome.
• Progression speed and treatment approach differ enormously depending on cancer type, so any decision about whether and when to treat must be made in consultation with your treating medical team.

Why Can't We Answer 'How Long Without Treatment'?

• The available material only covers national cancer registry statistics (survival rates) for patients who received treatment; it contains no statistics or figures on survival duration for untreated groups. Giving a specific timeframe or percentage for this question would therefore amount to baseless speculation, and we're unable to provide that.
• What the material does confirm, however, is that the nature of progression speed differs enormously from one cancer to another. Prostate cancer, for instance, often progresses slowly, and is described as one of the rare cancers where watching at set intervals without treatment—active surveillance—is listed as a standard option for low-risk groups. By contrast, acute leukemia among blood cancers is explicitly described in the material as a disease requiring treatment to begin immediately upon diagnosis, where even a single day's delay can matter.
• Because the speed of progression varies so dramatically even within the single umbrella term 'cancer,' the course of disease without treatment is something only your treating medical team can explain, based on full knowledge of cancer type, stage, histologic type, age, and any coexisting conditions.

What Difference Does Treatment Make? (Reference Figures from National Statistics)

• All figures in the material are 5-year relative survival rates for patient groups who 'received treatment'—they are not data directly comparing treated versus untreated outcomes. Based on Korea's 2019–2023 national cancer registry statistics (National Cancer Center Korea, Korea Central Cancer Registry), the rates are 96.9% for prostate cancer, 78.6% for stomach cancer, 75.6% for colorectal cancer, 55.7% for leukemia (overall), and 40.4% for liver cancer, with an all-cancers-combined 5-year relative survival rate of 73.7%.
• For reference, U.S. SEER data for 2016–2022 reports 98.2% for prostate cancer, 65.4% for colorectal cancer, 68.6% for leukemia, 39.8% for stomach cancer, and 21.9% for liver and intrahepatic bile duct cancer. The gap between the two countries' figures is explained as stemming substantially from differences in early-detection rates, in addition to treatment technology.
• All of these survival rates are group-wide averages—they are not numbers that predict an individual's outcome. Even within the same stage, results can vary considerably depending on age, coexisting conditions, and histologic type.

FAQ — Is It Possible to Simply Watch Cancer Without Treating It?

In some cases, yes. For example, in low-risk prostate cancer, 'active surveillance'—monitoring at set intervals using PSA, MRI, and repeat biopsy if needed—is included as a standard option, with a shift to treatment made only if signs of progression appear. That said, whether this applies depends entirely on the cancer type and risk group, and it's only feasible if the patient can reliably keep up with the scheduled testing. For fast-progressing cancers like acute leukemia, a watch-and-wait option is not part of the standard approach.

FAQ — Does Treatment Still Make Sense at Stage 4 or After Metastasis?

According to the material, treatment at the metastatic stage is sometimes aimed at 'control' rather than cure. Metastatic prostate cancer, for instance, can be managed over a long period with hormone therapy as the core treatment, and for liver cancer at an advanced stage, systemic drug therapy combining immune checkpoint inhibitors with angiogenesis inhibitors is now part of the first-line standard. For colorectal cancer, even at stage 4, treatment aimed at cure may be attempted if the sites of liver or lung metastasis can be surgically removed, which is why stage 4 colorectal cancer is described as covering a broader range of situations than in some other cancers. None of this promises a particular outcome—it's an individualized judgment that depends on cancer type, extent of metastasis, and overall physical condition.

Sources and Notes

• This content was prepared based on Korea's 2019–2023 national cancer registry statistics (National Cancer Center Korea, Korea Central Cancer Registry), SEER 2016–2022 data, and general information at the level of the National Cancer Information Center and NCCN patient guidelines. No specific figures for survival time without treatment exist in the available material, so we are unable to provide an answer on that point.
• This content is intended to provide general medical information, and actual diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment decisions should always be made in consultation with your medical team.